Insights Into Management of AEs in CLL

Perspectives of community physicians from Puerto Rico on optimal integration and side effect management of novel therapies

Puerto Rico August 14, 2021

Faculty Chair

Javier Pinilla, MD, PhD

Moffitt Cancer Center, Tampa, FL

More Information

  • Virtual series

Example Agenda

Export meeting topics

View Agenda

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A virtual, moderated roundtable discussion focusing on the treatment of chronic lymphocytic leukemia
  • Disease state and data presentations were developed in conjunction with a national or regional oncology expert
  • Insights on the following therapies were obtained: acalabrutinib, ibrutinib, zanubrutinib, obinutuzumab, rituximab, venetoclax

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection was accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprised 10–15 medical oncologists representing Puerto Rico

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.